Table 3 1-year, 5-year relative survival, and median survival by groups for patients diagnosed with lung cancer in 2018–2022 in Norway
From: Distribution and characteristics of malignant tumours by lung lobe
1-year RS (95%CI) | 5-year RS (95%CI) | Median survival (95%CI) | |
|---|---|---|---|
All | 61.2 (60.4–62.1) | 33.7 (32.7–34.7) | 20.1 (19.1–21.0) |
Side | |||
Right | 61.2 (60.1–62.4) | 34.6 (33.2–35.9) | 20.6 (19.1–22.0) |
Left | 61.2 (59.9–62.5) | 32.5 (31.0-34.1) | 19.6 (18.4–20.8) |
Lobe | |||
RUL | 61.1 (59.6–62.7) | 34.1 (32.3–35.9) | 20.8 (18.5–22.6) |
LUL | 60.4 (58.7–62.1) | 31.6 (29.8–33.6) | 18.8 (17.1–20.3) |
RML | 62.7 (59.0-66.6) | 36.5 (32.0-41.5) | 20.4 (16.3–25.5) |
RLL | 61.2 (59.3–63.1) | 34.9 (32.7–37.2) | 20.5 (18.6–22.6) |
LLL | 62.5 (60.4–64.7) | 33.9 (31.5–36.5) | 20.8 (18.8–23.0) |
Upper lobes / Lower lobes | |||
Upper | 60.8 (59.7–61.9) | 33.0 (31.7–34.3) | 19.5 (18.4–20.9) |
Lower | 61.9 (60.6–63.2) | 34.7 (33.2–36.4) | 20.7 (19.1–22.0) |
Sex | |||
Female | 65.3 (64.1–66.5) | 37.7 (36.3–39.2) | 25.3 (23.7–27.0) |
Male | 57.3 (56.1–58.5) | 29.7 (28.4–31.1) | 15.9 (14.9–16.8) |
cTNM | |||
I | 93.4 (92.4–94.4) | 68.5 (66.1–71.0) | 82.7 (77.3–87.3) |
II | 82.6 (80.2–85.1) | 49.9 (46.0-54.2) | 47.0 (40.8–53.4) |
III | 65.2 (63.1–67.2) | 25.2 (23.0-27.6) | 18.9 (17.8–20.1) |
IV | 31.4 (30.1–32.7) | 7.8 (6.8-9.0) | 6.1 (5.7–6.4) |
Unknown | 57.0 (51.2–63.4) | 27.1 (21.6–34.0) | 12.0 (9.3–15.6) |
Histology | |||
AC | 69.4 (68.2–70.7) | 41.5 (39.9–43.3) | 31.3 (29.4–33.6) |
SCC | 64.2 (62.3–66.1) | 34.8 (32.7–37.0) | 21.5 (19.3–23.5) |
NSCLC, NOS | 42.4 (39.0-46.1) | 18.4 (15.2–22.1) | 7.8 (6.9–9.5) |
Large-cell | 49.6 (41.4–59.3) | 25.8 (19.2–34.7) | 12.0 (7.8–17.6) |
SCLC | 36.9 (34.5–39.6) | 8.9 (7.4–10.7) | 8.3 (7.7-9.0) |
Carcinoid | 97.9 (95.0-100.9) | 90.7 (82.1-100.1) | NA |
Other | 60.3 (53.5–68.0) | 34.7 (26.4–45.7) | 27.4 (16.3–38.0) |
EGFR | |||
Not tested | 59.9 (55.8–64.2) | 43.6 (39.3–48.3) | 15.3 (14.1–16.2) |
Positive | 84.4 (81.3–87.7) | 46.8 (41.1–53.2) | 42.4 (36.0-49.4) |
Negative | 69.0 (67.6–70.5) | 40.2 (38.2–42.2) | 26.8 (25.4–28.8) |
Unknown | 67.9 (60.0-76.8) | 44.6 (36.0-55.4) | 30.4 (17.4–44.5) |